N. N. Sudareva, I. I. Tarasenko, D. N. Suslov, O. M. Suvorova, K. A. Kolbe, G. Y. Yukina, M. L. Tyndyk, Yu. G. Zmitrichenko, E. G. Korzhikova-Vlakh, “Doxorubicin delivery systems based on polypeptide nanoparticles for subcutaneous administration in cancer therapy”, Mendeleev Commun., 34:1 (2024), 18

Mendeleev Communications

RUS ENG

JOURNALS PEOPLE ORGANISATIONS CONFERENCES SEMINARS VIDEO LIBRARY PACKAGE AMSBIB

JavaScript is disabled in your browser. Please switch it on to enable full functionality of the website

	General information
	Latest issue
	Archive

	Search papers
	Search references

	RSS
	Latest issue
	Current issues
	Archive issues
	What is RSS

Mendeleev Commun.:
Year:
Volume:
Issue:
Page:
	Find

Personal entry:
Login:
Password:
	Save password
	Enter
	Forgotten password?
	Register

Mendeleev Communications, 2024, Volume 34, Issue 1, Pages 18–21
DOI: https://doi.org/10.1016/j.mencom.2024.01.006 (Mi mendc31)

This article is cited in 8 scientific papers (total in 8 papers)

Communications

Doxorubicin delivery systems based on polypeptide nanoparticles for subcutaneous administration in cancer therapy

N. N. Sudareva^ab, I. I. Tarasenko^a, D. N. Suslov^c, O. M. Suvorova^a, K. A. Kolbe^a, G. Y. Yukina^b, M. L. Tyndyk^c, Yu. G. Zmitrichenko^c, E. G. Korzhikova-Vlakh^ad

^a Institute of Macromolecular Compounds, Russian Academy of Sciences, St. Petersburg, Russian Federation
^b I.P. Pavlov First St. Petersburg State Medical University, St. Petersburg, Russian Federation
^c N.N. Petrov National Medical Research Center of Oncology, St. Petersburg, Russian Federation
^d Institute of Chemistry, St. Petersburg State University, St. Petersburg, Russian Federation

Full-text PDF (489 kB) Citations (8) Supplementary materials

DOI: https://doi.org/10.1016/j.mencom.2024.01.006

Graphic abstract: Doxorubicin delivery systems based on polypeptide nanoparticles for subcutaneous administration in cancer therapy

Abstract: Polypeptide-based doxorubicin delivery systems were prepared and their physicochemical and functional properties, such as size, encapsulation efficiency, stability, release of doxorubicin in various media and cytotoxicity, were characterized. An in vivo study revealed an effective reduction of tumor growth when these systems were administered subcutaneously.

Keywords: doxorubicin, synthetic polypeptides, nanoparticles, delivery systems, cancer treatment, subcutaneous administration.

Bibliographic databases:

Document Type: Article

Language: English

*Supplementary materials:*
		Supplementary_data_1.pdf	(835.7 Kb)

Citation: N. N. Sudareva, I. I. Tarasenko, D. N. Suslov, O. M. Suvorova, K. A. Kolbe, G. Y. Yukina, M. L. Tyndyk, Yu. G. Zmitrichenko, E. G. Korzhikova-Vlakh, “Doxorubicin delivery systems based on polypeptide nanoparticles for subcutaneous administration in cancer therapy”, Mendeleev Commun., 34:1 (2024), 18–21

Linking options:

https://www.mathnet.ru/eng/mendc31

https://www.mathnet.ru/eng/mendc/v34/i1/p18

This publication is cited in the following 8 articles:

Citing articles in Google Scholar: Russian citations, English citations
Related articles in Google Scholar: Russian articles, English articles

Registration to the website

Logotypes